Preclinical evaluation of a chemically detoxified pneumolysin as pneumococcal vaccine antigen. - Wikidata - wikimedia - TriplyDB

Preclinical evaluation of a chemically detoxified pneumolysin as pneumococcal vaccine antigen.

Preclinical evaluation of a chemically detoxified pneumolysin as pneumococcal vaccine antigen.

http://www.wikidata.org/entity/Q37619137

about

Kinetics of antibodies against pneumococcal proteins and their relationship to nasopharyngeal carriage in the first two months of life.Identification of SP1683 as a pneumococcal protein that is protective against nasopharyngeal colonization.

P2860

Q41990743-ED91EA04-E479-44B4-99BE-EB40DF69E3CA Q50199957-A8C365D7-F99D-4293-B000-82A7BD90EBBC

P2860

Preclinical evaluation of a chemically detoxified pneumolysin as pneumococcal vaccine antigen.

http://www.wikidata.org/entity/Q37619137

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 21 October 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Preclinical evaluation of a ch ...... pneumococcal vaccine antigen.

@en

Preclinical evaluation of a ch ...... pneumococcal vaccine antigen.

@nl

type

label

Preclinical evaluation of a ch ...... pneumococcal vaccine antigen.

@en

Preclinical evaluation of a ch ...... pneumococcal vaccine antigen.

@nl

prefLabel

Preclinical evaluation of a ch ...... pneumococcal vaccine antigen.

@en

Preclinical evaluation of a ch ...... pneumococcal vaccine antigen.

@nl

P1433

Q37619137-50B824BD-EC45-4656-B2A9-B57DB1A59BBB

P1476

Q37619137-D5650EE2-BB17-4B5E-82C0-5959C3CFDF3B

P2093

Q37619137-135DE74B-C809-4A87-ACC1-F945B078B4B3

Q37619137-9CEA90AA-E166-41BF-8753-61A1E2551878

Q37619137-A9BD63C9-045A-4514-9C6A-1720F5A4DDAF

Q37619137-B5C4286A-9120-416A-B6AA-090C6C43A5DC

Q37619137-D91A5284-6440-43D1-9C12-AA0A6C01260F

Q37619137-E070C4D1-4F3F-4E82-95BD-2867715B773B

Q37619137-F4C70D4B-989C-43C9-A38C-6BCB7C3899BE

P2860

Q37619137-06C4736D-11AD-4C7F-89AF-3E569D632223

Q37619137-07C412AA-AA8E-4ED2-8124-6AC2E2F25CEC

Q37619137-0CA7064D-7BB7-4057-9034-79FC18C3EB8F

Q37619137-16BA375F-FFFF-4677-905C-98E3C1C42407

Q37619137-25D3FFF4-9B7E-4E5B-8A1B-BCEC2A6C5934

Q37619137-296BC171-A806-4183-A20D-1C0FE9D8E538

Q37619137-29D68F4A-5F43-435D-8044-56128732DF06

Q37619137-2FDA7FF0-4032-4FC0-AAC9-F81544D2B430

Q37619137-316C84EE-E590-4CBD-9B89-C3BF310CB061

Q37619137-365135E2-AC4C-4860-8337-9C1F9C09E6B3

P304

Q37619137-8F9B4F96-6BBC-4166-B707-EE463689276B

P31

Q37619137-7962D129-25A9-4EBD-9365-FF1266EAF9B3

P356

Q37619137-53DFA3E1-C608-49E7-9884-975493421C19

P433

Q37619137-652260F6-BFE7-4FA6-BD36-ECF292B1BB12

P478

Q37619137-638C3522-8F95-45F6-9C17-1C66E58AAA11

P577

Q37619137-53F9DAF8-ED0C-4EBE-B8E4-C39B90AB3DEF

P698

Q37619137-AFF51BA4-3B50-49F6-AA80-901C06DBBAA8

P932

Q37619137-47EDF747-6CFC-415E-953B-E77AD5A4E9E7

P356

21645515.2016.1234553

P1433

Human Vaccines & Immunotherapeutics

P1476

Preclinical evaluation of a ch ...... pneumococcal vaccine antigen.

@en

P2093

Annick Vandercammen

http://www.w3.org/2001/XMLSchema#string

Emmanuel Di Paolo

http://www.w3.org/2001/XMLSchema#string

Emmanuel Mertens

http://www.w3.org/2001/XMLSchema#string

Fabrice Godfroid

http://www.w3.org/2001/XMLSchema#string

Philippe Denoël

http://www.w3.org/2001/XMLSchema#string

Philippe Hermand

http://www.w3.org/2001/XMLSchema#string

Vincent Verlant

http://www.w3.org/2001/XMLSchema#string

P2860

Redefining cholesterol's role in the mechanism of the cholesterol-dependent cytolysins

Invasive pneumococcal disease caused by nonvaccine serotypes among alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage.

Comparative virulence of Streptococcus pneumoniae strains with insertion-duplication, point, and deletion mutations in the pneumolysin gene

Immunization of mice with combinations of pneumococcal virulence proteins elicits enhanced protection against challenge with Streptococcus pneumoniae.

Dual function of pneumolysin in the early pathogenesis of murine pneumococcal pneumonia.

Construction and immunological characterization of a novel nontoxic protective pneumolysin mutant for use in future pneumococcal vaccines.

Molecular pathogenesis of pneumococcal pneumonia.

Density and duration of pneumococcal carriage is maintained by transforming growth factor β1 and T regulatory cells

Pneumolysin: a double-edged sword during the host-pathogen interaction.

Reduced virulence of a defined pneumolysin-negative mutant of Streptococcus pneumoniae.

P304

220-228

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/21645515.2016.1234553

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

2016-10-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27768518

http://www.w3.org/2001/XMLSchema#string

P932

5287308

http://www.w3.org/2001/XMLSchema#string